RARE
RARE
NASDAQ · Biotechnology

Ultragenyx Pharmaceutical In

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$24.77
+0.08 (+0.32%)
As of May 9, 1:27 AM ET ·
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 23 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +200.5% upside
Low Target $68.49
Average Target $74.44
High Target $103.74
Current Price $24.77
Current
$24.77
Target
$74.44
$68.49 $74.44 avg $103.74
Scenario Analysis
Bear Case
$68.49
176.5%
Low target
Base Case
$74.44
+200.5%
Avg target
Bull Case
$103.74
+318.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$42.37
-41.5% from high
52-Week Low
$18.29
+35.4% from low
50-Day SMA
$26.56
-6.7% vs SMA
200-Day SMA
$31.06
-20.3% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$74.44
+75.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%